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Abstract Acute Kidney Injury 
(AKI) previously known as acute 
renal failure (ARF) is a common 
problem in the paediatric emer-
gency wards with infections like 
sepsis and malaria being the com-
monest causes in Nigeria.  
It has been known by various no-
menclatures with a lack of stan-
dardised definition. This has made 
comparison of data very difficult. 
In the last decade, attempts have 
been made to standardize the defi-
nition by developing a classifica-
tion criterion termed “RIFLE”. 
This is in turn undergoing various 
modifications with the most re-
cent classification system devel-
oped by the Kidney Disease: Im-
proving Global Outcomes 
(KDIGO). 
Despite these interesting develop-
ments, the basis of these classifi-
cations which is the use of serum 
creatinine measurements is 
fraught with its own limitations. 
This has led to discovery of vari-
ous urinary and serum biomarkers 
like the cystatin C and neutrophil 
gelatinase associated lipocalin 
(NGAL) which appear to have 
very promising advantages over 
the well known creatinine meas-
urements. 
Management of AKI continues to 
be anticipatory with appropriate 
fluid therapy and adequate treat-
ment of infections. The benefits of 
furosemide and dopamine in man-
agement are still a constant source 
of debate. Treatment of life threat-
ening complications like hyper-
kalaemia and hypertension as well 
as maintaining the kidney through 
the period of non-function can lead 
to remarkable recovery of renal 
homeostatic function.  
 




Acute kidney injury (AKI) formerly known as acute 
renal failure (ARF) is a clinical syndrome that has been 
known by about twenty-five different nomenclature over 
the years. It evolved from the 18th century when it was 
first known as “ischuria renalis” (“ischuria” meaning 
suppression of urinary output) to the current terminol-
ogy “acute kidney injury” in the 21st century.  
Acute kidney injury has also been defined in over thirty-
five different ways in the last few centuries. It is widely 
defined as a clinical syndrome characterised by a sudden 
deterioration in renal function resulting in an inability of 
the kidneys to maintain fluid and electrolyte homeosta-
sis. It has also been defined as onset of reduced kidney 
function manifested by increased serum creatinine or a





As a result of the deficiency of a standardized definition, 
epidemiological data have been widely varying and dif-
ficult to compare. AKI or ARF is said to be encountered 
in about 3% to 10% of all admissions to neonatal inten-
sive care units with approximately 1% of ill children in 
the developed world having AKI at the time of admis-
sion. 
 
In Nigeria, incidence rates have been stated as 6.6% in 
Zaria, 4.7% in Portharcourt, 7.1% in Enugu and 3.13% 
in Ife. Esezebor et al, in Lagos found a prevalence of 
17.4 cases per 1000 children Mortality in acute kidney 
injury has been found to be high. Adedoyin et al re-
ported 57.9% in Ilorin, Esezebor et al  found 28.4% 
while Olowu et al  reported 46.2% in Ife.  
Anatomy and physiology of the Kidney 
 
The kidney is a paired, retroperitoneal organ located 
between the transverse processes of T12- L3 vertebrae. 
Fig 1 shows the gross anatomy of the kidney with the 
microanatomy of the nephron. The kidneys receive 25% 
of the cardiac output and the highly vascularised cortex 
takes over 90% of the renal supply. The kidney’s control 
over homeostasis allows it to regulate extracellular fluid 
(ECF) volume, osmolality, and acid-base balance. The
physiologic functions of the kidney are summarised in 
Fig 2. 
                     Fig 1: a. Cross section of the kidney b. The nephron (functio al unit of the kidney) 
A 
B 
Fig 2: Summary of the physiologic functions of the skin 
Causes and pathophysiology of acute kidney injury  
 
The causes of acute kidney injury can be divided into 
three based on their pathophysiologic mechanisms. 
These are highlighted in Table 1 
 
Prerenal injury  
 
Prerenal injury occurs when there is diminished effec-
tive circulating arterial volume resulting in inadequate 
renal perfusion and a decreased glomerular filtration rate 
(GFR). The kidneys are intrinsically normal with no 
evidence of renal parenchyma damage and prerenal  
injury is reversible once the blood volume and haemo-
dynamic conditonns have been restored to normal. The 
pathophysiology has been summarised in Fig 3.  
 
Intrinsic renal disease  
 
Renal injury results in damage to the renal parenchyma 
and it could result from prolonged renal hypoperfusion 
or from nephrotoxic renal insults. This form of AKI  
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could complicate diverse diseases of the renal paren-
chyma including diseases of the glomeruli, tubules, va -
cular and renal interstitial injury. The 3 phases of 
ischemic ARF can be seen in fig 3.  
Prerenal Intrisic renal Postrenal 
Hypovolaemia Glomerulonephritis Posterior urethral valves 
Acute diarrheoa disease Poststreptococcal GN Ureteropelvic junction obstruction 
Excessive vomiting Rapidly progressive glomeruonephritis Ureterovesicular junction 
Diabetes ketoacidosis Henoch-scholein purpura Ureterocele  
Severe hemorrhage HUS Tumor 
Burns Acute tubular necrosis Urolithiasis 
Toxic epidermal necrolysis Ischaemia (prolonged hypovolaemia Hemorrhagic cystitis 
Staphylococcal scalded skin syndrome (SSSS) Drugs (aminoglycosisdes,NSAIDS) Neurogenic bladder 
Hypotension Haemoglobinuria (excessive hemolysis)   
Sepsis Myoglobinuria   
Congestive cardiac failure Ethylene glycol   
severe anaphylaxis Heavy metals   
Drugs Contrast nephropathy   
  Interstitial nephritis    
  Penicllins,   
  sulphonamide   
  ciprofloxacin   
  NSAIDS   
  Infections   
  Acute pyelonephritis   
  HBV, EBV,HIV infections   
Table 1: Common causes of Acute Kidney Injury in children  
Fig 3: Pathophysiology of Prerenal 
and intrinsic renal failure  
(ischaemic ARF) 
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Post-renal causes  
 
Includes a variety of disorders characterized by obstruc-
tion of various parts of the urinary tract. An increase in 
fluid pressure proximal to the obstruction leads to renal 
damage with decreased renal function from back pres-
sure effect. 
 
Epidemiologic variation in aetiology of AKI 
 
Causes of AKI in industrialised countries have been 
found to be majorly due to intrinsic renal disease,  
postoperative septic shock (especially after open hart 
surgery) and organ/bone marrow transplantation. This is 
quite different from what obtains in developing nations 
like Nigeria.  
Secondary causes of acute renal failure like severe ma-
laria and sepsis were found to be the commonest aetiol-
ogy in Ife. Anochie et al, in Port-Harcourt found gastro-
enteritis and malaria as the most common cause of ARF
in older children while severe birth asphyxia and septi-
caemia were the prominent causes among neonates. Sep-
sis, acute diarrhoeal disease and haemoglobinuria were 
the leading causes of ARF in Ilorin.  
 
Definitions of terminology 
 
Oliguria: Reduction in urine output to less than 300ml/  
   m² per day or <1ml/kg/hr 
Anuria:  Defined as urine <75ml/day in an adult or       
   <1ml/kg/day in children 
Polyuria: Urine output >4ml/kg/hr 
Azotaemia: High nitrogenous waste as indicated by    
   high urea.   
Uraemia: Uraemia is the symptom complex reflecting  
   organ dysfunction that occurs when kidneys 




A good history will aid identification of the cause of 
AKI. Vomiting, diarrhoea and fever suggest pre-renal 
azotemia from hypovolaemia or a septicaemic illness. 
Antecedent skin or throat infection suggests intrinsic 
AKI from PSAGN. Drug history such as use of NSAIDS 
and aminoglycosides could be a pointer to acute tubular 
necrosis while flank masses may suggest obstruction as 
a cause of post renal AKI. 
Common manifestations due to failure of kidney  
function include oliguria or anuria, polyuria, anaemia, 




All suspected cases of AKI should at least have urine 
analysis, urine specimen for microscopy and culture and 
urinary biochemistry (Table 2). Serum electrolytes may 
show hyperkalemia, hyponatraemia and raised urea and 
creatinine levels. Full blood count, Chest X-ray, ab-
dominal utrasonography and roentgenograms, autoim-
mune screen, renal biopsy can be done to investigate the 
cause of the AKI. 
Table 2: Urine chemistries and osmolality in Acute Kidney 
Injury 
FENa= Una x Pcr/ Ucr x Pna 
 
Novel approaches to diagnosis 
 
The varying definitions of AKI made comparisons be-
tween studies very difficult. In 2004, the Acute Dialysis 
Quality Initiative group (ADQI) standardised the defini-
tion of AKI using the RIFLE criteria which was based 
on GFR, serum creatinine values and urine output. The 
term ARF was also replaced with AKI as defined by this
criteria such that it encompasses the entire spectrum of 
the syndrome and not just the aspect of failure. In 2007, 
the Acute Kidney Injury Network (AKIN) proposed 
some modifications to this criterion that was based on 
time in relation to the creatinine values or documented 
oliguria. Recently in 2012, Kidney Disease: Improving 
Global Outcomes (KDIGO) proposed another classifica-
tion system which combines the RIFLE and AKIN  
criteria 
 
RIFLE  is a mnemonic for level of severity & outcome. 
There are 3 levels of severity; Risk, Injury and Failure 
and 2 outcomes measures; Loss of renal fuction and End
-stage renal disease (ESRD). The pRIFLE a modified 
form for paediatric use can be seen in Table 3.  
 
Table 3: The modified RIFLE criteria for paediatric patients 
(pRIFLE) 
Schwartz equation -K* Height (cm)/ SCr (mg/dl) where K is constant 
 
The RIFLE and AKIN classifications use changes in 
serum creatinine to estimate loss in GFR. However, s -
rum creatinine has many limitations. It differs with age, 
sex, dietary intake and muscle mass and doesn’t reflect 
dynamic changes but only increases when there is sub-
stantial loss of renal function. It cannot be used as a 
monitoring tool after dialysis as it is easily dialysed and 
its secretion can be impaired by drugs like trimethoprim. 
This led to the discovery of newer biomarkers that can
aid earlier detection of kidney injury (Table 4).   
 
Neutrophil Gelatinase Associated Lipocalin (NGAL) is 
secreted by renal tubular epithelium and serum levels  
Urinary indices Prerenal Intrinsic 
Renal 
Urine osmolality (mosmol/kg H2 0) >500 <350 
Urine SG >1.020 <l.020 
Urinary Na < 20 >20 
Fractional excretion  of filtered Na 
 (%) FENa 
< 1 >1 
CLASS Change in eCCl 
(by Schwartz) 
Urine Output 
Risk Decrease by 25 % <0.5 ml/kg/hr X 8 hrs 
Injury Decrease by 50 % <0.5 ml/kg/hr X 16 hrs 
Failure Decrease by 75 %, or 
< 35ml/min/1.73m² 
<0.3 ml/kg/hr X 24 hrs 
or ANURIA > 12 hrs 
Loss Failure > 4 weeks   
End Stage Renal 
Disease 
Failure > 3 months   
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rise markedly after epithelial damage following is  
chaemic or nephrotoxic injury. There is increase in ur e 
levels of NGAL before rise in serum creatinine and has 
both diagnostic and prognostic value for AKI. 
 
Table 4: Protein biomarkers for early detection of acute  
kidney injury 
Cystatin C is a protein secreted by all nucleated cells. It 
is minimally influenced by weight, sex, race, age, mus-
cle mass but mostly reflects a reduction in GFR rather 
than acting as a marker of renal tubular damage. It rises 
earlier than serum creatinine  
Kidney Injury Molecule – 1 (KIM-1) is an epithelial 
cell adhesion molecule that is expressed at a low level in 
normal kidneys. It is highly up regulated in the proximal 
tubules after ischaemic or toxic AKI. Urinary KIM-1 is 
used to distinguish ischaemic AKI from pre-renal dis-
ease and chronic renal disease and can be used as a pre-
dictor of graft loss in kidney transplant patients. 
 
Treatment of Acute Kidney Injury 
 
Management is generally directed at treating any life 
threatening features, attempting to halt or reverse the 
decline in renal function and if unsuccessful providing 
support by renal replacement anticipating renal  
recovery. Provided the patient can be maintained 
through the period of non-function and no further insults 
accrue, the kidney is remarkable in its ability to recover 
its normal homoeostatic role. 
  
Fluid management  
 
The major goal is to restore and maintain intravascular 
volume. AKI may manifest with hypovolemia, eu-
volemia or volume overload and an estimation of fluid 
status is a prerequisite for initial and ongoing therapy. 
Children with intravascular volume depletion require 
prompt and vigorous fluid resuscitation. Initial therapy 
includes normal saline or lactated Ringer’s solution at 
20 ml/kg over 30 minutes and may be repeated twice if 
necessary, after careful monitoring to avoid possible 
fluid overload. If anuria persists after 3 fluid boluses, the 
possibility of an intrinsic or post renal failure should be 
entertained. 
Fluid input and output records, daily weights, physical 
examination, and serum sodium concentration guide 
ongoing therapy. During the recovery phase, children 
develop significant polyuria and natriuresis and may 
become dehydrated if appropriate adjustments in fluid 
requirements are not made.  
 
Oliguria in the presence of volume overload requires 
fluid restriction (previous day’s output plus insenible 
water loss (300ml/m2/day) and possibly intravenous 
administration of furosemide, mannitol or both. Ration-
ale for the use of loop diuretics in ARF is due to the 
inhibition of the Na+/K+/2Cl pump in the thick ascend-
ing limb of the loop of Henle with subsequent decrease 
in Na+/K+2ATPase activity, which reduces the oxygen 
requirements of these cells and thus their susceptibility 
to ischaemic damage. However, recent studies have not 
demonstrated any differences in outcome of patients 




The use of low dose (1–3 µg/kg/min) dopamine had 
been long advocated to increase renal perfusion by caus-
ing vasodilatation in critically ill patients. Howev r, 
recently there has been a lot of debate in the literature 
about its benefit.  
 
Electrolytes and acid-base balance  
 
Hyperkalaemia (>5.5mEq/L) can be managed by the use 
of diuretics, sodium bicarbonate therapy, insulin gucose 
infusions and dialysis. The primary treatment of hypona-
tremia is free water restriction and use of hypertonic 
saline (3%). Oral phosphate binders (eg calcium carbon-
ate) can be used to treat both hyperphosphataemia and 
hypocalcemia. Moderate acidosis to severe acidosis 
should be treated with oral or intravenous sodium  
bicarbonate. 
Hypertension resulting from hyperreninemia can be 
managed with salt and water restriction and diuretic  
administration; calcium channel blockers (amlodipine )
or β blockers (propranolol; labetalol) can be used.  
Hypertensive urgency/emergency should be treated with 
continuous infusions of sodium nitroprusside, labetlol 
or esmolol  
The anaemia of ARF is usually mild and may require 
transfusion of packed red blood cells if the hemoglobin 
level falls below seven g/dL. Avoidance of nephrotoxic 
drugs like aminoglycosides and dose adaptations should 
be taken for medications that are largely eliminated by 
the kidney.  
 
Renal replacement therapy  
 
Dialysis: This aims at removing endogenous and exoge-
nous toxins and to maintain fluid, electrolyte and  
acid-base balance until renal function returns. It uses the 
principles of diffusion of molecules in solution across a  
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semi-permeable membrane along an electrochemical 
concentration gradient.  
Dialysis can be in form of peritoneal dialysis 
(continuous or intermittent), haemodialysis, haemofiltra-
tion and haemodiafiltration.  
Indications for dialysis include volume overload with 
evidence of hypertension and/or pulmonary oedema 
refractory to diuretic therapy; persistent hyperkalaemia; 
severe metabolic acidosis unresponsive to medical man-
agement; neurologic symptoms (altered mental status, 
seizures), blood urea nitrogen greater than 100–150 mg/
dL (or lower if rapidly rising); calcium/phosphorus im-
balance with hypocalcaemic tetany; poor nutrition lead-
ing to progressive loss of weight. 
 
The choice between haemodialysis and peritoneal dialy-
sis depends on the overall clinical condition, availability 
of technique, aetiology of the AKI, institutional prefer-
ences and specific indications or contraindications. I  
general, peritoneal dialysis is the preferred method in 
infants and younger children. Specific contraindications 
include abdominal wall defects, bowel distention, perfo-
ration or adhesions, and communications between the 
abdominal and chest cavities. Haemodialysis has the 
distinct advantage of rapid correction of fluid, electro-
lyte and acid-base imbalances and may be the treatment 
of choice in haemodynamically stable patients, espe-
cially older children. Disadvantages include the require-
ment for vascular access, large extracorporeal blood 
volume, heparinization, and skilled personnel.  
 
Diet: Aggressive nutritional support is important. Ade-
quate calories to account for maintenance requirements 
and supplements to combat excessive catabolism must
be provided. Oral feeding is the preferred route of ad-
ministration.  
Surgical Care: Patients with AKI secondary to obstruc-
tion frequently require urologic care.  
 
Renal treatment modalities for the future 
 
Experimental treatments include anti-endothelin anti-
bodies; oxygen free radical scavengers, inhibitors f 
inducible nitric oxide synthetase, all designed to reduce 
renal damage occurring in the context of sepsis.  
Infusions of atrial natriuretic peptide (ANP) or a syn-
thetic analogue anaritide may improve renal perfusion.  
Recombinant erythropoietin can reduce ischaemic renal 
injury. Therapeutic strategies in the more distant future 
may include bioartificial kidneys as a renal replacement 
modality and possible stem cell therapy to improve na-
tive kidney recovery.  
 
Complications of AKI 
 
Infections develop in 30-70% of patients with AKI due 
to impaired defenses from uraemia and excessive use of 
antibiotics. Other complications may be cardiovascular 
(hypertension, congestive heart failure and pulmonary 
oedema); gastrointestinal (anorexia, nausea, vomiting, 
ileus, bleeding); haematologic (anaemia, platelet dys-




Recovery of renal function is likely after AKI resulting 
from prerenal causes, HUS, ATN, acute interstitial ne-
phritis, or tumor lysis syndrome. Recovery of renal 
function is unusual when AKI results from most types of 
rapidly progressive glomerulonephritis, bilateral renal 






AKI is a significant cause of morbidity and mortaliy n 
children. The main focus of physicians should be to pre-
vent its occurrence (by adequate rehydration of ill chi -
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